Corgenix Medical Corporation holds a unique position in the healthcare field with its targeted focus on medical diagnostic products in the hemostasis, autoimmune and vascular area.  As a result of this focus, the company has become one of the foremost experts in the diagnosis and measuring of various components of the blood coagulation (clotting) system, measuring risk of vascular occlusion and thrombotic risk factors.

Corgenix, Inc. specializes in the development and  manufacturing of numerous products for the medical diagnostic industry. Corgenix, Inc.,  and in conjunction with the ELITech Group provide worldwide marketing for these products through both direct and indirect sales and distribution channels. Since its inception in 1990, Corgenix has demonstrated a strong and continued growth in this market and has a formidable reputation as an innovative provider of healthcare products. Our menu of over 140 diagnostic products is sold on a worldwide basis to hospitals, clinical laboratories, commercial reference laboratories, and research institutions. Corgenix was the first commercial company in the United States to develop and manufacture the anticardiolipin assay used in the detection of a number of autoimmune and vascular diseases. Since 1990 the Corgenix product line has grown to include products used in the diagnosis of five important areas of healthcare: autoimmune disease, vascular disease, infectious disease and liver disease. The worldwide market potential for HA in the monitoring of both liver disease and arthritis should bring enormous opportunity to the Company.

CorgenixOnline.com is a website designed to allow constant and consistent access to the products our company offers. CorgenixOnline.com offers in depth information on our product lines, as well as, information on each specific product. You can also visit AspirinWorks.com to get all the information on this exciting product.